• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCompugen
    Picture of Compugen logo

    CGEN — Compugen News Story

    $1.940.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSuper Stock
    • Market Cap
      $183.77m
    • Enterprise Value
      $58.47m
    • Revenue
      $72.76m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CGEN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CGEN Dividends
    All News

    NASDAQ RESUMED AT 08:35 AM

    Picture of Compugen logoCompugen
    12/03/2020 13:35
    NASDAQ RESUMED  CGEN.O  AT 08:35 AM
    

    Recent news on Compugen

    See all news
    • Israel's Compugen Q2 revenue more than doubles, net loss narrows

      03/08/2026 12:08
    • Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors

      12/02/2026 12:26
    • Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million

      17/12/2025 12:09
    • Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer

      21/07/2025 12:02
    • Brief: Compugen Announces Leadership Transitions Effective September 2025

      13/05/2025 12:41

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.